"The
Report Opportunities in Human Embryonic Stem Cell (hESC) Products -
Trends and Forecasts to 2017 provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
Stem
cells are primitive cells found in all multi-cellular organisms that
are characterized by self-renewal and the capacity to differentiate
into any mature cell type. Categorized by stage of life, several
broad categories of stem cells exist, including:
- Embryonic stem cells, derived from blastocysts
- Post-natal stem cells, derived from newborn tissues
- Adult stem cells, found in adult tissues – including hematopoietic stem cells, mesenchymal stem cells, neural stem cells, and more
- Induced pluripotent stem cells, reprogrammed from adult cells
- Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body
View
Report At :http://www.marketresearchreports.biz/analysis/174817
Embryonic
stem cells are stem cells derived from the inner cell mass of a
blastocyst, which is a stage reached four to five days
post-fertilization. They are the most pluripotent of all stem cell
types and can develop into over 200 different cell types of the human
body. Human embryonic stem cells (hESCs) were first derived from
mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and
independently by Gail R. Martin. In 1995, the first successful
culturing of embryonic stem cells from non-human primates occurred at
the University of Wisconsin-Madison. Another breakthrough followed at
the University of Wisconsin-Madison in November 1998 when a group led
by Dr. James Thomson developed a technique to isolate and grow hESCs
derived from human blastocysts.
As
such, embryonic stem cells are still a relatively new discovery, as
the first mouse embryonic stem cells (ESCs) were derived from embryos
in 1981, but it was not until 1995 that the first successful
culturing of embryonic stem cells from non-human primates occurred
and not until November 1998 that a technique was developed to isolate
and grow embryonic stem cells from human blastocysts.
Market
Segments
To
facilitate research resulting from these advances, a large and
diverse market has emerged for human embryonic stem cell products,
platforms, and technologies. In total, the global sales of these
items compose the hESC product marketplace. One thriving component of
this marketplace is the segment of companies that sell hESC research
products to scientists.
Termed
“research supply companies” or “research product vendors,”
large companies selling human embryonic stem cell research products
include Life Technologies, BD Biosciences, Thermo Fisher Scientific,
EMD Millipore, Sigma Aldrich, Lonza, R&D Systems, and STEMCELL
Technologies, as well as more than 60 other suppliers that range in
size from multinational corporations to small specialty companies.
Together, these research supply companies represent a substantial
annual percentage of hESC product sales.
As
of 2013, the following product categories accounted for more than 85%
of all global hESC research product sales:
- Embryonic stem cell culture products
- Embryonic stem cell lines
- Antibodies to embryonic stem cell antigens
- Bead-based embryonic stem cell separation systems
- Embryonic stem cell protein purification and analysis tools
- Tools for DNA and RNA-based characterization of embryonic stem cells
- Embryonic stem cell specific growth factors and cytokines
- Tools for embryonic stem cell gene regulation
- Embryonic stem cell services and mechanisms for in vivo and in vitro stem cell tracking
In
addition, pharmaceutical companies also have intense interest in
human embryonic stem cell product development. Because of their
plasticity and unlimited capacity for self-renewal, hESCs have been
proposed for use in a wide range of pharmaceutical applications,
including:
- Drug target validation and testing
- Toxicology testing
- Tissue engineering
- Cellular therapies
- Personalized medicine
- And more
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/174817
For
this reason, development of hESC products by the pharmaceutical
sector also represents a thriving segment of the global hESC product
marketplace. Of particular interest to this community is the
potential for use of hESCs to heal tissues that have a naturally
limited capacity for renewal, such as the human heart, liver and
brain.
Furthermore,
within the pharmaceutical sector, development of new drugs is
extremely costly and the success rate of bringing new compounds to
the market is unpredictable. Therefore, it is crucial that
pharmaceutical companies minimize late-stage product failures, such
as suboptimal pharmacokinetic properties or unexpected toxicity, that
can arise when candidate drugs enter the clinical testing stages.
To
achieve this, it would be highly desirable to test candidate drugs
using in vitro assays of high human relevance as early as possible.
Because hESCs have the potential to differentiate into all of the
mature cell types of the human body, they represent an ideal cell
type from which to design such drug screening assays.
In
summary, the unifying factor within the hESC product marketplace is
that all companies involved need to understand market forces, trends,
metrics, and financials, in order out-compete the competition and
make more profitable decisions. Producing hESC products can involve
complicated and confusing decisions, but it doesn't have to. Claim
this report to reveal the current and future needs of the hESC
marketplace, so you can focus your marketing efforts on the most
profitable products, in the most promising research areas, and within
the most lucrative domestic and international markets.
Your
competitors would prefer you didn’t buy this report. But when you
do, you’ll be gaining invaluable stem cell market insights to help
you control and dominate this market.
Market
Characterization
It
is also crucial for companies involved in the hESC product
marketplace to understand the funding environment which supports hESC
research. Within the United States, the federal government is
currently an important, although not dominant, source of funding for
stem cell research. The reason is that U.S. states are spending
almost as much as the federal government on stem cell research and
are actually spending more than the federal government on human
embryonic stem cell (hESC) research. Private sources also contribute
a huge amount of funding to stem cell research, with analysis of
recent large gifts summing to over $1.7 billion.
Worldwide,
hESC funding also varies widely, with countries varying from “very
permissive” to “very limited” in how each elects to fund hESC
product and technology development within the federal, private, and
not-for-profit sectors.
While
there is conclusive evidence that entering the hESC marketplace is
financially worthwhile, there are complicating factors for companies
that hope to enter the market. Specifically, human embryonic stem
cell research is heavily encumbered by patents held by the University
of Wisconsin's Wisconsin Alumni Research Foundation (WARF), which
creates significant challenges for companies seeking to develop new
products.
As
such, this market research report explores the complex intellectual
property (IP) landscape affecting development of human embryonic stem
cell products, providing clear guidance for companies entering or
already within the market, from collaborating with WARF to less
costly alternatives - such as circumventing the claims, conducting
research off-shore, and developing embryonic stem cell products for
other species.
Methods
and Methodology
As
a technology company, BioInformant’s standard techniques derive
market data from sources that utilize high-quality primary research
inputs. The following constitute the basis for our research and
analysis:
- Preliminary Research - Examination of studies that need further confirmation by the scientific community, using extensive secondary research.
- Fill-gap Research - Selectively sampled and focused primary research as a fill-gap strategy.
- Historic Analysis - Historic analysis of all end-user industries/markets, requiring technology and market evaluations, growth projections, and market size estimation of end-user markets.
- Historic Supply Chain/Raw Materials Analysis - Comprehensive analysis of data for each primary market segment.
- Data Consolidation - Merging historic end-user market data to yield consolidated primary market data.
- Cross Linking - Primary market data (historic) is compared with resulting end-user consolidated market data and the variance in percentages between data sets is calculated by year.
- Variance Determination - A median figure for each year with a tolerance range equal to twice the variance percentage is determined.
- Projections - End-user markets are projected forward (typically 2013-17) based upon historic growth, technology and market trends, and primary research from the market place.
- Variance Factorization - Consolidation of projected end-user market data to yield derived primary market data. The data is adjusted to the historic variance determinations, as above. The resulting data is further verified by confirmatory primary research.
- Confirmatory Primary Research - Resulting data is presented from companies or individuals participating as research partners. Variations from derived data are adjusted to reflect primary research based consensus.
- Electronically Based End-User Surveys - In addition to the methods described above, electronically based end-user surveys are utilized. Surveys are distributed to a comprehensive panel of academic and industry representatives working within the market segment of interest.
Furthermore,
the market intelligence contained in this report was compiled using a
broad range of sources, including:
- Grant Funding Databases (NIH database, DoD database, and more)
- Patent Databases (USPTO, WIPO)
- Scientific Publication Databases (PubMed, Highwire Press, Google Scholar)
- Product Launch Announcements (Trade Journals, Company Websites, PR News Feeds)
- Financial Data (SEC Filings, Investor Relations Packets)
- International Surveys (Electronically Distributed End-User Surveys)
- And More
Finally,
a rare and valuable feature of this report is an end-user survey of
247 researchers (101 U.S. / 146 International) that identify as
having human embryonic stem cell research as their core research
focus. These findings reveal hESC researcher needs, technical
preferences, key factors influencing buying decisions, and more.
Scientist
survey results include:
- Emerging trends within the hESC research sector
- Insights into hESC product selection, purchasing decisions, and preferred providers
- Crucial trends and unmet market needs within the hESC marketplace
- “Tested Sentences” for selling to hESC scientists
- Breakdown of the marketing methods used by industry participants
- And much more
Leverage
these insider insights to make effective product development
decisions, create targeted marketing messages, and produce higher
prospect-to-client conversion rates.
Conclusions
In
summary, growth in stem cell research has exploded in the past
decade, and so the market to supply hESC products and technologies
has grown to meet this huge demand. To profit from this rapidly
expanding market, you need to understand your key strengths relative
to the competition, intelligently position your products to fill gaps
in the market place, and take advantage of crucial hESC trends. Claim
this must-read industry report to optimally position yourself to sell
hESC products.
Key
Findings Include:
Charts,
Trends, and Metrics for the hESC Product Market
Trends
for hESC Grants, Scientific Publications, and Patents
5-Year
Market Size Projections (2013-2017)
Profitable
Opportunities for hESC Product and Technology Development
Consumer
Behavioral Patterns and Preferred Providers
Preferred
Species for ESC Research
Crucial
Trends and Unmet Market Needs
Breakdown
of the Marketing Methods Used by Industry Participants
“Tested
Sentences” for Selling to hESC Scientists
End-User
Survey of hESC Researchers (101 U.S. / 146 International)
Finally,
all BioInformant products are backed by a full 60-Day Money Back
Guarantee. If the strategies and tools aren't helpful to you, we'll
cheerfully refund your money, and you can keep the product.
BioInformant honors our 60-Day Money Back Guarantee policy like
nobody else around.
Learn
profit activators that you can trigger on your business right now -
or your competition will.
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment